Physician profile
Eric Abkin
NPI 1982303160
$2,327.91
in general payments reported to CMS, 2019-2025
13 companies · $529 in 2025
The $529 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $516 · 2024: $1,283 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,249 · Travel and Lodging: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,248.54 |
| Travel and Lodging | $1,079.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,096.36 | 2024 | |
| Medtronic, INC. | $311.11 | 2023 | Signia, Signet |
| W. L. Gore & Associates, INC. | $190.41 | 2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Atricure, INC. | $174.60 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Davol INC. | $137.09 | 2025 | Channel Drain |
| Phathom Pharmaceuticals, INC. | $132.96 | 2025 | Voquezna |
| Stryker Corporation | $86.93 | 2024 | 1788 |
| Olympus America INC. | $65.82 | 2024 | Olympus, Hd 3cmos Autoclavable Camera Head |
| Merck Sharp & Dohme LLC | $38.86 | 2024-2025 | Keytruda, Bridion |
| Galvanize Therapeutics, INC | $36.32 | 2024-2025 | Aliya System |
| Ethicon US, LLC | $24.52 | 2025 | Echelon Endopath |
| Astrazeneca Pharmaceuticals Lp | $18.72 | 2025 | Tagrisso |
| Vertical Pharmaceuticals, LLC | $14.21 | 2023 | Dsuvia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Abkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.